Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
51.7M
-
Shares change
-
+11.2M
-
Total reported value, excl. options
-
$703M
-
Value change
-
+$175M
-
Put/Call ratio
-
0.81
-
Number of buys
-
77
-
Number of sells
-
-45
-
Price
-
$13.60
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q2 2018
145 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q2 2018.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.7M shares
of 139M outstanding shares and own 37.26% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8.3M shares), OppenheimerFunds, Inc. (7.81M shares), BlackRock Inc. (7.08M shares), FIRST MANHATTAN CO (4.53M shares), STATE STREET CORP (4.03M shares), VANGUARD GROUP INC (3.94M shares), Vivo Capital, LLC (1.9M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.5M shares), NORTHERN TRUST CORP (1.06M shares), and ACUTA CAPITAL PARTNERS, LLC (1.03M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.